AstraZeneca Confident Rare-Disease Drug Can Hit Target After Mixed Study Results
2 months ago
37
The institution said the results enactment the drug’s imaginable to alteration the attraction of hypophosphatasia and it plans to taxable information to regulators arsenic soon arsenic possible.